A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

NCT03536390 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was cancelled prior to the enrollment of any participants.

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT)
DRUG: Placebo

Sponsor

Pfizer